Detalhe da pesquisa
1.
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
Nature
; 620(7974): 651-659, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468627
2.
Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
PLoS Pathog
; 15(12): e1008154, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815961
3.
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.
bioRxiv
; 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077016
4.
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Oncogene
; 43(6): 395-405, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066089
5.
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.
Cancer Discov
; 13(2): 454-473, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331284
6.
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
bioRxiv
; 2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711814
7.
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma.
Res Sq
; 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131684
8.
MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer.
Cancer Res
; 79(24): 6215-6226, 2019 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582380